The detection of Alzheimer’s disease, which affects more than 60 million people in the world, has always been a medical problem from the complexity and high cost of traditional diagnostic methods.
Until now, the identification of this pathology has accurately required invasive procedures, such as lumbar or expensive zoomaterial, the methods are little accessible to most patients in primary medical care.
Discovery that can change the diagnosis of Alzheimer’s disease
A recent study published in Nature Medicine notes before and after this disease. Scientists from Spain, Sweden and Italy have developed a test capable of detecting Alzheimer using a simple blood sample, analyzing the P-TAU217 protein as a key biomarker.
Alzheimer | Scientists find that those who have this habit increase the risk of memory problems
Alzheimer | The neurologist revealed, which is an ideal magnesium for the brain: it strengthens memory and improves training
The study was advanced by well -known institutions, such as the hospital Del Mar, Barcelonabeta Brain Research Center (BBRC), Barcelona Autonomous University, Pascal Maragall and Barcelona Institute of Science and Technology (BIST).
The clinical study was attended by 1767 people with cognitive symptoms, on average 73 years. The assessment was carried out both in specialized and in primary medical care centers using the Lumipulse automated platform, widely accessible in many hospitals and laboratories.
Early and affordable diagnosis: The near future Alzheimer
The results were stunning: the P-TAU217 biomarker showed a very high accuracy for identifying the disease, even at the initial stages. The most revolutionary conclusion is that it allows a screening of a mass population from primary medical consultations, bringing the diagnosis to all levels of society.
Dr. Ela Rodriguez, the head of the neurology department at the Marqué de Valdecilla-Vidival University Hospital, emphasized the importance of this progress, emphasizing that “democratizes the diagnosis of accuracy” and eliminates the need for invalid or excessively expensive procedures.
The practical consequences of this scientific promotion
The integration of this blood test into medical protocols can be implemented in the near future, which allows people with symptoms of cognitive impairment to quickly gain access to a specific, economic and simple diagnosis.
The detection of Alzheimer in the early stages not only improves the quality of life of patients, but also opens the door for personalized treatment methods and new clinical studies aimed at curbing or slowing down the progression of the disease.
They find a mushroom that can regenerate neurons and improve memory: this will help to fight the disease of Alzheimer and Dementia
Alzheimer: An early symptom of the disease that you could determine in the kitchen or soul
Although a large validation and approval of regulatory authorities is still required, this conclusion is a historical step in the fight against neurodegenerative diseases and can change the future of public health throughout the world.
With one of the blood samples, we are closer to a change in the fate of millions of people affected by Alzheimer’s disease.